Informatics integration: The bedrock of NCE selection

Drug Discovery Today: BIOSILICO

Volumn 1, Issue 1, 2003, Pages 14-17

  Scott, Richard K ^a  

^a De Novo Pharmaceuticals   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; COMPUTER MODEL; COMPUTER PROGRAM; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; HIGH THROUGHPUT SCREENING; INDUSTRIALIZATION; INVESTMENT; JOB PERFORMANCE; MARKET; MEDICAL DECISION MAKING; MEDICAL INFORMATICS; PHYSICAL CHEMISTRY; PIPELINE; PROBLEM SOLVING; PURCHASING; REVIEW; SCIENCE; TIME;

EID: 15744376504     PISSN: 17418364     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1478-5382(03)02231-5     Document Type: Review

References (17)

1. Dyer, G. and McDonough B. (2001) Vertical targets for knowledge management vendors. International Data Corporation. Document No. 25535
2. Scott, R.K. (2002) Enabling technologies: delivering the future for pharmaceutical R&D. Bio/Chem oinformatics Data Warehousing. SCRIP Reports Document No. BS1158
3. Accenture Press Release (2002) Accenture and Tripos join forces to deliver 'scientific workbench' to improve discovery performance. 21 February (http://www.accenture.com)
4. IBM (1998) Pharm a 2005, an industrial revolution in R&D. (http://www-1.ibm.com/services/strategy/files2/gw510-9220-00f.pdf)
5. Veverka, M.J. (2000) Accenture 'speed to value'. (http://www.accenture. com/xdoc/en/industries/hls/pharma/Speed_to_value.pdf)
6. Clauss, B.L. and Underwood, D.J. (2002) Discovery informatics: its evolving role in drug discovery. Drug Discov. Today 7, 18
7. Beresford, A.P. et al. (2002) The emerging importance of predictive ADME simulation in drug discovery. Drug Discov. Today 7, 109
8. Bains, W. et al. (2002) Evolutionary computational methods to predict oral bioavailability QSPRs. Curr. Opin. Drug Discov. Dev. 5, 44-51
9. Lipinski, C. A. et al. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Res. 23, 3-25
10. Cargill, J.F. and MacCuish, N.E. (1998) Object-relational databases: the next wave in pharmaceutical data management. Drug Discov. Today 3, 547-551
11. Scott, R.K. (2002) From targets to NCE's: informatics integration. Computational Challenges in the Post-Genomic Age-II (March 11-13, 2002, Durham NC. USA; http://www.sdsc.edu/Workshops/ postgenomic/agenda.html)
12. Grady, R.B. (1992) Practical Software Metrics for Project Management and Process Improvement, Prentice Hall
13. Coleman, A.L. (1998) Java Commerce Business Perspective. White Paper (http://java.sun.com/products/commerce/docs/business/business.html)
14. Soley, R. et al. (2002) Model Driven Architecture. White Paper (ftp://ftp.omg.org/pub/docs/omg/00-11-05.pdf and http://www. mg.org/mda/presentations.htm)
15. Koprowski, S.P., Jr and Barrett, J.S. (2002) Data warehouse implementation with clinical pharmacokinetic/pharmacodynamic data. Int. J. Clin. Pharmacol. Ther. 40, S14-S29
16. Coleman, J.B. et al. (1995) Development and submission of a nonclinical (pharmacology/toxicology) CANDA. Regul. Toxicol. Pharmacol. 22, 46-53
17. Holt, T.G. et al. (2000) The design and development of an integrated natural products screening database. J. Biomol. Screening 5, 421-433